Physician profile

Paul Lajos

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Amherst, NY

NPI 1437342797

$18,365.07

in general payments reported to CMS, 2019-2025

26 companies · $2,952 in 2025

The $2,952 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$6,765.91
Travel and Lodging$3,444.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$615.00
Consulting Fee$605.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $3,632.83 2021-2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
W. L. Gore & Associates, INC. $2,556.12 2019-2025 Gore Tag Conformable Thoracic Endoprosthesis, Product In Development, Gore Viabahn Vbx Balloon Expandable Endo
Medtronic, INC. $2,050.57 2021-2024 Ellipsys Vascular Access System, Endurant Iis, Abre
Silk Road Medical, INC. $1,553.97 2019-2022
Medtronic Vascular, INC. $1,257.67 2019-2020
Becton, Dickinson and Company $1,220.00 2024-2025
Penumbra, INC. $1,080.25 2021-2025 Ruby Coil
Endologix LLC $943.46 2022-2025 Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System
Boston Scientific Corporation $884.89 2021-2024 Eluvia, Ranger, Angiojet Ultra 5000a
Abbott Laboratories $700.52 2023-2024 Esprit, Diamondback Peripheral, Jeti Peripheral Catheter
Cook Medical LLC $592.20 2019-2024 Zilver Ptx, Cook, Zenith Spiral-Z
Getinge USA Sales, LLC $339.63 2019-2020
Bard Peripheral Vascular, INC. $289.06 2021-2025 Set Aspirex S 10f 110cm, Rotarexs 6 F X 135 Cm, Venovo
Kerecis Limited $229.22 2019-2024 Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose
Shockwave Medical, INC $163.72 2024 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Show all 26 companies
CompanyGeneral paymentsYearsTop products
Artivion, INC. $144.83 2023 Bioglue Surgical Adhesive, Vascular
Cardiovascular Systems INC. $132.48 2022
Organogenesis INC. $124.98 2024 Novachor, Apligraf, Nushield
Argon Medical Devices, INC. $121.62 2023 Cleaner
Medela LLC $112.72 2022
Stryker Corporation $106.11 2025 Artix Mt, Flowtriever Catheter, S, Ct Thrombectomy System Kit
Tactile Systems Technology INC $34.47 2022-2025 Nimbl, Flexitouch Plus
Pfizer INC. $31.14 2022
Lemaitre Vascular, INC. $23.99 2022
Smith+Nephew, INC. $22.67 2024 Collagenase Santyl
Teleflex LLC $15.95 2023 Manta

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paul Lajos

$18,365.07

in general payments reported 2019-2025

Years
2019-2025
Top company
Inari Medical, INC.
Context
The $2,952 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).

https://glasscript.com/doctor/292450/paul-lajos

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.